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Background: It has been known for nearly 20 years that, in cardiovascu-
lar operations, a significant inverse relationship exists between clinical
outcomes and the volume of procedures performed. Interestingly, this
relationship persists 2 decades after it was recognized. Objective: The
purpose of this study was to examine the relationship between hospital
volume and in-hospital deaths in 3 cardiovascular procedures: coronary
artery bypass grafting, elective repair of abdominal aortic aneurysms,
and repair of congenital cardiac defects. Methods: The database includes
all patients who were hospitalized in New York State during the years
1990 to 1995. Using standard logistic regression techniques, we analyzed
the relationship between hospital volume and outcome. Results: No cor-
relation exists between hospital volume and in-hospital deaths in coro-
nary artery bypass grafting. Statewide, 31 hospitals performed 97,137
operations over the 6-year period (overall mortality rate, 2.75%). By
contrast, most of the hospitals statewide (195 of 230 hospitals) per-
formed 9847 elective abdominal aortic aneurysm repairs with an over-
all mortality rate of 5.5%. In abdominal aortic aneurysm operations, a
significant inverse relationship between hospital volume and in-hospital
deaths was determined. Sixteen hospitals performed 7199 repairs for
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T he current environment of market forces in healthcare has renewed interest in exploring the relation-
ship between volume and outcomes to discern varia-
tions in performance that are related to case load.
Admittedly, managed care organizations and large pur-
chasers up to now have focused mainly on price as a
basis for contractual decisions. But as their experience
in this market evolves, quality may become an increas-
ingly important consideration for decision-making.
It has been known for nearly 20 years that, in cardio-
vascular operations, there is a significant inverse rela-
tionship between clinical outcomes and the volume of
procedures performed by health care providers.1 This
recognition has led to a variety of responses. At one end
of the spectrum lies a regulatory response, which has
involved the regionalization of specialty care in a few
institutions and the closing of low-volume programs.
At the other end of the spectrum is the “laissez-faire”
approach; the observations about volume-outcome
relationships ostensibly led to no change in providers’
or purchasers’ behavior. The middle ground contains
the creation of quality improvement programs, which
continuously survey outcomes and give performance
data to providers to encourage them to improve care.
We believe that the 20-year mark is an appropriate time
to assess (1) whether continued volume-outcome rela-
tionships exist in cardiovascular surgery, (2) what the
response has been if they do exist, and (3) whether
these efforts have been adequate in achieving the goal
of better patient care.
We examine volume-outcome relationships in 3 cate-
gories of cardiovascular procedures (coronary artery
bypass grafting [CABG], operations for congenital car-
diac disease, and abdominal aortic aneurysm [AAA]
repairs) in New York State during the years 1990
through 1995. The reasons for selecting these proce-
dures were 3-fold. First, they reflect very different
annual patient volumes. In New York State, the average
annual number of patients undergoing operations dur-
ing the 6 years of study were 16,190 CABG proce-
dures, 1641 repairs of nonruptured AAAs, and 1199
pediatric cardiac procedures. The large number of
patients undergoing CABG clearly flags this as an
important public health issue. Although the population
of neonates and infants is considerably smaller, the
aggregate number of life-years at risk is substantial,
given the nearly 8 decades of life expectancy for new-
born infants. Second, in all 3 areas, the “red flag” of
significant inverse relationships between volume and
outcome has been raised. However, these areas have
been studied with varying degrees of intensity; CABG
operations have received the most attention in the liter-
ature, and pediatric cardiac operations have received
the least.2-8 Finally, there has been a major difference in
the professional and regulatory approach toward man-
aging quality. In CABG surgery, we have seen the most
comprehensive approach, regulatory intervention, and
the creation of a continuous quality improvement pro-
gram. This program has been organized under the aus-
pices of the Cardiac Advisory Committee, in conjunc-
tion with the New York State Department of Health. It
entails standardized data collection; feedback of risk-
adjusted results to surgeons, hospitals, and the public;
the distribution of predictive instruments to surgeons
(which allow them to make preoperative predictions);
and the creation of specific quality improvement efforts
at individual hospitals.2-6 In pediatric cardiac opera-
tions, clinical data are routinely collected by the
Cardiac Advisory Committee, but until recently, analy-
ses were not given to the providers.8 By contrast, there
is no statewide effort to monitor the outcomes of AAA
operations.
Methods
Data sources. Discharge abstract data for individual
patients who underwent any of the 3 types of cardiovascular
420 Sollano et al The Journal of Thoracic and
Cardiovascular Surgery
March 1999
congenital cardiac defects. A significant inverse relationship (which was
most pronounced for neonates) was found between volume and death.
Conclusions: The importance of these findings lies in the rather striking
difference between the volume-outcome relationship found for opera-
tions for abdominal aortic aneurysms and congenital cardiac defects
and the lack of such a relationship for coronary artery bypass grafting.
This observation may be largely explained by the quality improvement
program in New York State for bypass operations since 1989. If so, these
results have important implications for expanding the scope of quality
improvement efforts in New York State. (J Thorac Cardiovasc Surg
1999;117:419-30)
operations during the period from 1990 through 1995 were
extracted from the Statewide Planning and Research
Cooperative System (SPARCS). These data are maintained
by the New York Department of Health and contain informa-
tion on every patient discharged from an acute care facility,
including patient disposition (eg, death), age, gender, princi-
pal procedure, and principal diagnosis codes. Each patient
record also contains a code that identifies the discharging
hospital and whether the patient was transferred from another
hospital or a long-term care facility.
The International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM) was used to
define 3 cohorts of patients.
Patients who underwent elective AAA repairs had a princi-
pal ICD-9-CM procedure code of 38.44 (resection of abdom-
inal aorta), with a primary or secondary diagnosis code of
44.14 (abdominal aneurysm without mention of rupture).
Patients undergoing operations for ruptured AAAs were
excluded because emergency operations of this sort have an
across-the-board high mortality rate of 50% and do not neces-
sarily reflect the institution’s experience with a planned pro-
cedure. Because there is no quality improvement program in
place for AAA operations in New York State, there is no
incentive for hospitals or surgeons to overuse the emergency
category; the exclusion of patients who underwent emergency
AAA repair thus should not impose a bias in our analysis.
Patients who underwent CABG had ICD-9-CM procedure
codes in the range from 36.10 through 36.19 (broadly defined
as bypass anastamosis for heart revascularization) as a prin-
cipal procedure. This included single and multiple aorta-
coronary bypasses, single and double internal thoracic–coro-
nary artery bypasses, and other bypass anastomoses.
Patients with congenital heart disease were selected by pri-
mary and secondary ICD-9-CM procedure codes that were
derived from a recent article by Jenkins and colleagues.7 The
procedure codes and the number of patients in each category
are given in Table I. We excluded all premature patients or
patients with extremely low birth weight (diagnostic codes,
765.0-765.17) and those patients who underwent closure of
an isolated patent ductus arteriosus at less than 3 months of
age. In these categories of patients, other factors far outweigh
the effect of surgical expertise on patient outcome. We also
excluded infants whose cardiac or chest procedures were a
result of trauma and who did not have a diagnostic code indi-
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Table I. Complexity categories
Category Operation description ICD-9-CM procedure codes
1 (n = 918) Closed valvotomy 35.0-35.04
Atrial septectomy 35.41-42
Repair of atrial septal defect 35.50-52, 35.60-61, 35.70-71
Patent ductus arteriosus closure or pulmonary artery band 38.85
Systemic–pulmonary artery shunt 39.0
Thoracic vessel repair, direct 38.35
2 (n = 1069) Open valvotomy 35.1-35.14
Annuloplasty 35.34
Infundibulectomy 35.34
Subaortic stenosis resection 35.35
Repair of ventricular septal defect 35.53, 35.62, 35.72
Repair of endocardial cushion defect 35.54,35.63,35.73
Repair of tetralogy of Fallot 35.81
Thoracic vessel repair, prosthesis 38.45
Septal surgery, unspecified 35.70, 35.39
Revision of procedure 35.95
3 (n = 563) Valve replacement 35.2-35.28
Repair of total anomalous pulmonary venous connection 35.82
Repair of truncus arteriosus 35.83
Atrial inversion 35.91
Right ventricular–pulmonary artery conduit 35.59
Left ventricular–aorta conduit 35.93
Cavopulmonary shunt 39.59
Repair of vessel, including aortopulmonary window 39.59
4 (n = 283) Arterial switch operation 35.84
Total cavopulmonary anastomosis 35.94
Diagnosis of hypoplastic left heart syndrome 746.7*
Note: Search included “Other operations on valves of the heart” (35.99); no cases found.
(Adapted from Jenkins KJ, NewBurger JW, Lock JE, Davis RB, Coffman GA, Iezzoni LI. In-hospital mortality for surgical repair of congenital heart defects: pre-
liminary observations of variation by hospital caseload. Pediatrics 1995:95:323-30.)
*ICD-9-CM diagnostic code.
cating a congenital cardiac anomaly. Finally, all atrial, septal,
and ventricular defects that were repaired by transcatheter
interventions (as evidenced by a lack of procedure code 39.61
[ie, cardiopulmonary bypass]) were eliminated. We made one
exception to the classification by including only those proce-
dures from ICD-9 category 39.59, “repair of other vessels,”
that also coded for cardiopulmonary bypass.
The analysis of pediatric data was stratified by age (up to 30
days, 31 days–l year, 1-12 years, and 13-17 years) and adjust-
ed for the complexity of the surgical repair (in neonates we also
stratified for procedure complexity). The surgical complexity
categories (SCC) were derived from Jenkins and colleagues7
(Table I) and were subsequently used by Hannan and col-
leagues8 in a more recent article. The least complex surgical
repairs are found in SCC I, whereas the most complex repairs
are in SCC IV. Hospital volume was scaled into smaller units
to accommodate the interpretation of the logistic model.
The regression analysis examined the relationship between
hospital volume and in-hospital deaths. Hospital volume was
defined as the number of times each type of operation was
performed in a facility over the 6-year period and was calcu-
lated by aggregating patient data by the hospital identifier
code for each of the surgical cohorts. To evaluate whether
there was a trend over the 6-year period of study, we re-exam-
ined the data by 2-year intervals. We did not have access to
physician identifiers and, therefore, do not address physician
volume-outcome relationships.
Data analysis. The relationship of hospital volume to inpa-
tient death was examined with the use of a standard logistic
regression procedure. The dependent variable was a binary
indicator of in-hospital death. For CABG and AAA repair, we
calculated the probability of dying for each patient, after con-
trolling for differences in statewide hospital volume, age, and
sex in the baseline-regression model. The baseline pediatric
models were stratified by age and controlled for the com-
plexity of procedure but not controlled for sex (in the
neonates, as mentioned, we also stratified for procedure com-
plexity). In addition, we undertook separate models for each
level of surgical complexity within the neonate category
when significant interaction between surgical complexity
level and hospital volume was detected. For each model, we
explored the effect of controlling for a variety of other inde-
pendent variables, including race, payer status, admission sta-
tus, transfer in from another acute health care facility, and
service intensity weights. These weights were used as a proxy
for illness severity and are based on diagnosis-related group
(DRG) ratings of cost for care. We express the relationship
between the outcome and predictor variables as odds ratios
(ORs) and represent uncertainty using 95% confidence inter-
vals (CIs). An OR of less than 1.0 denotes the existence of an
inverse volume-outcome relationship.
Model performance was measured by the static compliance
(C
stat), which calculates how well the logistical model dis-
criminates between those patients who lived and those
patients who died; a value of 1 indicates perfect discrimina-
tion. Additionally, we performed a goodness-of-fit test for
each logistic model with the Hosmer-Lemeshow statistic. The
Hosmer-Lemeshow statistic compares the observed number
of individuals with each outcome with the number expected,
as derived by the logistic equation.10 Large Hosmer-
Lemeshow values indicated that the observed number of indi-
viduals is different from the expected number of individuals,
thereby providing evidence of a poor fit or, more simply, a
logistic model with poor predictive abilities.
Hospitals were grouped by volume; each group had an
equivalent number of patients, at least 6 deaths, and equal
intervals of volume between ranges. The smallest cohort was
grouped into 10 volume ranges, and the largest cohort was
grouped into 15 volume ranges. For each volume range, we
computed the mean actual mortality rate and mean expected
mortality rate, which were based on probabilities predicted
by the baseline regression analysis.
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Table II. Logistic regression results*: New York State, 1990-1995
Procedure Variables Coefficient P value OR 95% CI C
stat HL
CABG (n = 97, 137) Hospital volume/10,000 0.0014 .88 1.001 0.983-1.020 0.669 0.917
Female 0.3975 .001 1.488 1.374-1.612
Age 0.0587 .001 1.060 1.056-1.065
Nonruptured AAA repair
(n = 9847) Hospital volume/100 –0.2459 .001 0.782 0.722-0.847 0.679 0.677
Female 0.2224 .02 1.249 1.029-1.517
Age 0.0783 .001 1.081 1.068-1.095
Pediatric congenital 
cardiac operation: Hospital volume/100 –0.0579 .001 0.944 0.921-0.967 0.617 0.034
all ages (n = 7199) SCC I Reference group
SCC II –0.3191 .007 0.727 0.577-0.916
SCC III 0.5037 .001 1.655 1.292-2.120
SCC IV 0.9437 .001 2.569 1.915-3.448
HL, Hosmer-Lemeshow.
*The prediction of in-hospital death. Hospital volume is not a predictor of in-hospital death for CABG but is a significant predictor of outcome for AAA repair and
pediatric congenital operations. Age and female sex are significant independent predictors of death for both CABG and AAA operations.
Results
The total 6-year cohort for CABG comprised 97,137
patients and for elective AAA operation comprised
9847 patients. The 6-year cohort for pediatric congen-
ital cardiac operation comprised 7199 patients overall,
including 1045 neonates (up to 31 days of age), 1985
infants (31 days–1 year of age), 3735 children (1-12
years of age), and 434 adolescents (13-17 years of
age).
CABG. In New York State, where certificate-of-need
regulation is in place as a mechanism for planning the
distribution of heart surgery programs, 31 hospitals are
presently certified to perform CABG. A total of 31 hos-
pitals performed on average 3703 procedures over the
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Fig 1. Actual versus expected in-hospital mortality rates for CABG operations in New York State, 1990-1995.
The average hospital volume per annum is shown for a 6-year period. The number of hospitals in each category
appears at the top of each solid bar. No volume-outcome relationship is noted.
Fig 2. Actual versus expected in-hospital mortality rates for nonruptured AAA repair in New York State, 1990-
1995. The average hospital volume per annum is shown for a 6-year period. The number of hospitals in each cat-
egory appears at the top of each solid bar. A significant inverse volume-outcome relationship is noted.
6-year period, ranging from 70 cases in the lowest vol-
ume hospitals to 1421 cases in the highest volume hos-
pitals, annually. The overall mortality rate for CABG
was 2.75% during the study period. In the baseline
regression model, we found no significant association
between hospital case volume and death for patients
who underwent CABG (OR, 1.001 for hospital vol-
ume/10,000 cases; Table II). We plotted the observed
and expected mortality rates in Fig 1. Examining the
same data set by 2-year intervals did not reveal an asso-
ciation between in-hospital deaths and hospital volume.
We then expanded the model by 9 variables to include
other patient demographics, insurance status, service
intensity weights, and mode of admission (ie, elective,
urgent, emergency, transferred from another acute care
facility). The association between hospital volume and
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Fig 3. Hospital volume is shown for a 6-year period for operations for congenital cardiac defects in neonates (up
to 30 days of age) in New York State, 1990-1995. The number of hospitals in each category appears at the top of
each bar.
Fig 4. Hospital volume is shown for a 6-year period for operations for congenital cardiac defects in infants (31
days–1 year of age) in New York State, 1990-1995. The number of hospitals in each category appears at the top
of each bar.
deaths in the expanded model remained the same. In
both models, age and female sex were significant pre-
dictors of death.
AAA repairs. During the study period, there were 195
hospitals in New York State that performed elective
AAA repair. The overall mortality rate for AAA repair
was 5.5% over the 6 years. On average, the lowest vol-
ume hospitals performed only 2 cases on a yearly basis
(with an average mortality rate of 13%), whereas the
highest volume center performed 27 cases per year on
average with an overall mortality rate of less than 2%.
The baseline regression model revealed a significant
inverse relationship between hospital case volume and
in-hospital deaths (OR, 0.782 for hospital volume/100
cases; 95% CI, 0.722,0.847; P < .001; Table II). Using
the results of this model, we plotted the observed and
expected mortality rates for the different volume groups
in Fig 2. Reanalyzing the data in 2-year intervals contin-
ued to show the association between low volume and
adverse outcome (1990-1991: OR, 0.419; 95% CI,
0.278-0.631; 1992-1993: OR, 0.562; 95% CI,
0.378,0.835; 1994-1995: OR, 0.496; 95% CI,
0.323,0.764). Expanding the model by the 9 variables
yielded a similar association between hospital volume
and deaths (OR, 0.827; 95% CI, 0.756,0.904; P < .001).
As with CABG, age and female sex were significant pre-
dictors of death for elective repair of AAAs (Table II).
Pediatric cardiac surgery. Sixteen hospitals have a
certificate of need for performing surgery of congenital
heart disease in New York State. For all pediatric patients
who undergo heart procedures, the overall mortality rate
for the entire cohort was 7.3% (<31 days of age, 19.8%;
31 days–1 year of age, 9%; 1-12 years of age, 3.5%; 13-
20 years of age, 2.5%). A significant inverse relationship
was demonstrated between volume and death in all pedi-
atric patients (OR, 0.944 for hospital volume/100 cases;
95% CI, 0.92, 0.97; P < .001; Table II).
The relationship was most pronounced for neonates
(<31 days of age) in hospitals with an annual volume
below 50 patients that displayed mortality rates greater
than twice those observed in the highest volume hospi-
tal. Fig 3 depicts the observed and expected deaths by
hospital volume. For patients aged 31 days to 1 year, a
significant inverse relationship was also found (Fig 4).
A marginal inverse volume-outcome relationship was
found (P = .579) in patients aged 1 to 12 years. No sig-
nificant relationship was found in patients aged 13 to
17 years. Although the overall effect of volume to out-
come exists in 3 of the 4 age groups, the magnitude of
the effect diminishes with increasing age.
We then examined the volume-outcome relationship
for the entire pediatric population, adjusting for surgi-
cal complexity. The interaction between surgical com-
plexity and volume was most pronounced for neonates
The Journal of Thoracic and
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Table III. Pediatric congenital cardiac operations*: New York State, 1990-1995
Procedure Variables Coefficient P value OR 95% CI C
stat HL
Neonates Hospital volume/100 
(1-30 days  (baseline model) –0.4520 .001 0.636 0.546-0.742 0.64 0.05
of age;n = 1045) SCC I (n = 455) –0.1482 .18 0.862 0.695-1.069 0.53 0.11
SCC II (n = 167) –0.5640 .01 0.569 0.361-0.895 0.64 0.21
SCC III (n = 201) –0.5197 .001 0.595 0.443-0.799 0.68 0.13
SCC IV (n = 222; –1.2204 .001 0.295 0.167-0.522 0.77 0.36
individual models)
Infant Hospital volume/100 –0.3288 .001 0.720 0.622-0.832 0.62 0.21
(31 days-1 year SCC I (Reference group)
of age; n = 1985) SCC II –0.3034 .13 0.738 0.500-1.091
SCC III 0.5079 .03 1.662 1.048-2.636
SCC IV 0.9258 .03 2.524 1.082-5.888
Childhood Hospital volume/100 –0.1199 .06 0.887 0.784-1.004 0.72 0.33
(1-12 years SCC I (Reference group)
of age; n = 3735) SCC II 1.1591 .001 3.187 1.557-6.523
SCC III 1.8703 .001 6.490 3.091-13.630
SCC IV 3.0080 .001 20.247 9.644-42.509
Adolescence Hospital volume/100 1.0946 .60 2.988 0.052-173.300 0.70 0.75
(13-17 years SCC I (Reference group)
of age; n = 434) SCC II –0.2824 .78 0.754 0.104-5.447
SCC III 1.1639 .15 3.202 0.651-15.760
SCC IV –10.760 .98 0.000 0.000-999.00
HL, Hosmer-Lemeshow.
*Hospital volume, age, and surgical complexity as predictors of in-hospital death in pediatric patients.
(Table III). As a result, we reanalyzed the neonatal
group, stratifying by surgical complexity. We found no
volume-outcome relationship among neonates in SCC I
(OR, 0.862 for hospital volume/100 cases); however,
significant relationships were found in SCC II, III, and
IV (OR, 0.569, 0.595, 0.295 for hospital volume/100
cases; Table III).
Expanding the baseline model in the neonates to
include 9 additional variables (excluding Medicare and
advanced age and including gender), hospital volume
remained a significant predictor. The addition of the 9
variables resulted in findings similar to the baseline
model (OR, 0.566; 95% CI, 0.471, 0.681; P < .001).
Although the fit of the model is marginally better (C
stat,
0.67 vs 0.64), we focus on the simpler model because
of concerns about the accuracy of reporting, such vari-
ables as race or payer status.
For all of the data sets, robust standard errors com-
puted under the generalized estimating equation
approach were similar to those from the standard logis-
tic regression, suggesting that correlation within hospi-
tals was negligible.
Discussion
Our analysis reveals that for several, but not all, areas
of cardiovascular operations, important variations
remain in patient outcomes across hospitals in New
York State. The statewide volume of CABG operations
in New York State increased from 13,644 in 1990 to
18,821 in 1995 among the 31 hospitals that performed
heart operations. Despite an increase in the severity of
illness, our data suggest that overall mortality rates
declined from 3.28% to 2.49% during the same time
period. We did not find a significant inverse relation-
ship between hospital volume and outcomes over the
entire period from 1990 through 1995.
After the seminal studies by Luff and colleagues,1 a
considerable amount of literature has emerged con-
cerning CABG, describing the existence of an inverse
relationship between the outcomes and the experience
of providers. In New York State, Hannan and col-
leagues2-6 showed in various studies that there was a
marginal relationship between hospital volume and
outcomes but a substantial relationship between the
volume of activity of the individual surgeon and out-
comes. Furthermore, they demonstrated that since
1989 there was a notable decline in risk-adjusted mor-
tality rates for various surgeon volume groups, but the
risk-adjusted mortality rates for patients of surgeons
who performed 50 or fewer surgical interventions in
1992 was still 36% higher than the mortality rates for
patients of surgeons who performed 150 or more
CABG procedures.2 No studies of volume-outcome
relationships in New York State after 1992 were
reported to the Cardiac Advisory Committee’s clinical
database. Our analysis focused on hospital perfor-
mance only, and we found no significant volume-out-
come relationship in this area between 1990 and 1995,
nor did we find any such relationships after disaggre-
gating the data into 2-year periods. The possibility
exists that there still is a relationship between surgeon
volume and outcome, but if the trend that Harman and
colleagues found persists, it is likely to be a relatively
small one.
AAA repairs and pediatric cardiac operations, how-
ever, present a very different picture. Already in 1989,
investigators showed that elective operations for the
repair of AAA displayed a significant inverse relation-
ship between volume and death in New York State.9
This analysis, and our previous research, suggests that
this relationship persists over a decade later,11 with the
vast majority of hospitals still performing very few sur-
gical procedures annually (84% of the 195 hospitals
that perform AAA repairs perform fewer than 10 elec-
tive cases per year).
Our conclusions for the pediatric population are 3-
fold. First, pediatric patients undergoing cardiac surgi-
cal procedures in general demonstrate a significant
inverse relationship between hospital volume and hos-
pital death. Second, when stratified by age, complexity
overshadowed volume as a significant determinant of
death among neonates, infants, and children up to age
12 years, but patients older than 12 years did not
demonstrate these differences. Finally, this relationship
is most pronounced in neonates for whom hospitals
with volumes below 50 patients per year had mortality
rates that were 2 times higher than in the highest hos-
pital volume group. These findings are consistent with
those of Jenkins and colleagues,7 who reported similar
results in a review of congenital heart defect operations
in California in 1988 and in Massachusetts in 1989. In
these cohorts, Jenkins and colleagues demonstrated a
3-fold increase in in-hospital deaths when comparing
the ORs of centers performing 10 to 100 procedures
per year with those centers performing more than 300
procedures. A recent study, with the use of the Cardiac
Surgery Reporting System database, documents similar
results for New York State; both hospital and surgeon
volume are significantly and negatively associated with
in-hospital deaths.8 One difference between the 2 stud-
ies is that Hannan and colleagues found the volume-
outcome differences to persist for both high-complexi-
ty and low-complexity cardiac procedures, whereas in
our study the lowest complexity category did not show
a significant inverse relationship between adverse out-
comes and hospital experience.
426 Sollano et al The Journal of Thoracic and
Cardiovascular Surgery
March 1999
Our analysis suggests not only that variations in hos-
pital performance exist within the state but also that
there are important differences in the approaches used
to improve the quality of care in these 3 clinical areas.
In CABG procedures, the Cardiac Advisory Committee
and the New York State Department of Health in 1989
created a prospective clinical data collection effort for
cardiac operations, patients, and all hospitals that vol-
untarily report information regarding risk factors,
deaths, and complications to this Cardiac Surgery
Reporting System. These data are used to analyze actu-
al and risk-adjusted outcomes, and these data are
reported to the public, surgeons, and hospitals as a
basis for quality improvement efforts. When analyzed
by surgeon volume, several studies have attributed part
of the decline in overall risk-adjusted deaths to these
quality improvement efforts.2-6 In particular, these
studies found that many low-volume surgeons stopped
performing CABG in New York State. Not all of the
decline, however, could be explained by New York’s
quality improvement program, because a similar trend
was found in states with no such program. Pediatric
cardiac operations also fall within the cardiac opera-
tions reporting system, but this has, until now, not led
to a continuous quality improvement program; data
have not been fed back on a regular basis to hospitals,
and only recently have the first risk-adjusted mortality
rates for various hospital and surgeon volume ranges
been published. In AAA repairs, no prospective state-
wide patient registries exist that can form the founda-
tion for quality improvement efforts.
Why do these differences exist? The CABG opera-
tion is a high-volume surgical procedure that was intro-
duced just after certificate-of-need regulation was
implemented in New York State in 1966. The existence
of certificate-of-need regulation meant that the state
and providers were already concerned with the quality
of heart operation programs, which then could provide
the foundation for establishing a continuous quality
improvement program. Pediatric cardiac surgery also
falls under certificate-of-need regulation in the state of
New York; however, the data collected within the car-
diac surgery reporting system were not analyzed and
reported to providers on a regular basis, probably
because pediatric cardiac surgery is a catch-all for
many procedures and involves much lower patient vol-
umes. Hospitals do not need a certificate of need to per-
form AAA repair, and compared with CABG, the vol-
ume of patients for this procedure is much lower. These
factors probably contributed to the absence of a
statewide monitoring and quality improvement system.
What lessons can we draw from comparing the per-
formance of providers in the area of cardiovascular
surgery in New York State using the SPARCS data-
base? We would underscore that there are serious limi-
tations to the analysis of risk-adjusted outcomes on the
basis of hospital discharge databases, such as
SPARCS.9,11 First, these databases do not contain the
physiologic data with which to distinguish patients.
Second, for the data that are coded, there is substantial
variation in accuracy and completeness, resulting in
both overreporting and underreporting. Such errors
could be unintentional or deliberate by those who
might game the system. Third, the level of detail con-
tained in these databases do not allow one to distin-
guish pre-existing conditions from complications of the
hospitalization. As a result of these limitations, we
chose in our baseline analysis to control only for age,
sex, and volume, which are less subject to error, and we
still found a significant volume-outcome relationship
for 2 of the 3 procedures, which remained when addi-
tional predictive variables were considered.
Despite the limitations of hospital discharge databas-
es, these data strongly indicate the existence of varia-
tions in outcomes among hospitals in the treatment of
congenital heart disease and aortic aneurysms. In the
area of AAA repairs, such variations have been identi-
fied before and should be a strong stimulus for the
community of vascular and general surgeons to devel-
op the infrastructure for rigorous clinical data collec-
tion as a basis for quality improvement. We believe that
this should be a particularly strong stimulus because,
otherwise, regulatory and purchasing decisions might
be based on data that are not of research quality and are
inadequate for judging the severity of illness. The data
collection infrastructure can form the basis for a quality
improvement program.
In pediatric cardiac surgery, prospective clinical data
collection is in place but as yet has not led to a contin-
uous quality improvement program, as it has in adult
coronary revascularization. The recent analysis of pedi-
atric data collected by the Cardiac Advisory Com-
mittee, and our findings here, offer a strong rationale
for building a continuous quality improvement pro-
gram for pediatric surgery. With respect to highly com-
plex neonatal cardiac procedures, where the volume-
outcome relationship was particularly strong, the break
between institutions with comparatively high and low
mortality rates clearly is in excess of 100 patients, and
possibly over 200 patients. Given the volume needed to
support low-death operations, the state population
could support many fewer institutions than the 16 cer-
tified hospitals where this procedure is performed now.
This constitutes a strong argument for centralization of
heart surgery in the first year of life.
The literature distinguishes between 2 hypotheses as
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the potential explanations for the inverse volume-out-
come relationship.9 The first hypothesis, practice
makes perfect, is based on the supposition that a greater
volume of patients should allow the operative team to
develop greater skills and judgment in the management
of complex clinical conditions and therefore achieve
better outcomes. The alternative hypothesis, selective
referral patterns, is that operating teams with superior
outcomes attract a greater number of patients. These
hypotheses have very different policy implications.
Under the first hypothesis, and in an environment
where cost containment is important, centralization in
the least costly institution would be a reasonable strat-
egy; institutions would logically improve outcome with
further experience and accomplish this at a lower cost.
Obviously, if the second hypothesis holds, then this
strategy would not be reasonable, and centralization
should be in those institutions with better outcomes. In
our view, these hypotheses are not mutually exclusive;
a more accomplished team will see selective referral
and will show a greater improvement in outcomes as a
result of the larger practice than would a less accom-
plished team. Therefore, should future analyses of pri-
mary clinical data confirm our findings, we believe that
excellence would be served by centralizing infant heart
procedures in those institutions with an established
track record.
In conclusion, historically the existence of certifi-
cate-of-need regulation was probably an important
incentive for the profession and the state to create a
continuous quality improvement program. This obser-
vation raises the question whether certificate-of-need
regulation should be extended to other sophisticated
surgical programs, such as AAA repair, or whether
market forces provide enough of an incentive to devel-
op such quality improvement programs. The policy
issues raised by choosing between regulation and mar-
ket forces are complicated and beyond the scope of this
article. Whatever the mechanism, however, the data
emerging from this study provide a powerful challenge
to the profession to develop programs to monitor qual-
ity. Administrative databases, which are easily accessi-
ble, can be used to focus efforts. These studies need to
be supplemented by careful observation studies with
greater clinical detail to form a foundation for quality
improvement programs. New York State’s quality
improvement program in CABG is a major step in the
right direction, but there is still room for improvement.
First, there is insufficient detail about the processes of
care to pinpoint the problem. Second, the focus on
short-term mortality should be extended to long-term
death outcomes and the symptoms of patients, as
reflected by their functional status and quality of life,
particularly in light of the growing emphasis on the
appropriate use of surgical procedures. Finally, we
need to understand better how the information is used
by surgeons, hospitals, the public, purchasers, payers,
and referring physicians.
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Discussion
Dr Jack M. Matloff (Los Angeles, Calif). This topic has
been a recurring one. New York State has frequently been the
venue for exploring the thesis that volume and clinical out-
comes of a variety of procedural therapies can be related. It is
therefore not surprising that one can find support in the liter-
ature for almost any relationship. For cardiothoracic surgeons
there have been personal biases about the assumptions inher-
ent in SPARCS in the past and the modeling that influences
the conclusions drawn. Quite apart from that, your observa-
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tion that the data are administrative or observational underlies
one of the real problems and, that is, that the results are sub-
ject to confounding as an expression of variability of case
mixes. This is particularly important because other studies
have shown that the more case mixes are adjusted, the small-
er are the apparent benefits of increased volumes of opera-
tions. I also find myself wondering whether or not the juxta-
position of the 3 groups of patients and the differences in
numbers created a problem for you at any time and whether
or not you ever considered just studying 1 of the cohorts. 
Now, having made these observations, I would like to turn
to the reasons that I think we have to be very careful about
such studies. Justification for concern can be appreciated from
two juxtaposed quotes, one from Victor Fuchs at Stanford,
noted health care economist, and the other from Oscar Wilde.
Dr Fuchs notes that “the only independent variable in the
equation for calculating the cost of health care is the volume
of services given.” So, volume clearly is an important issue on
the price side. By the same token, Oscar Wilde has made the
companion observation that we should “avoid the person who
knows the cost of everything and the value of nothing.”
We do not now have and probably never will have enough
resources to provide all the needed health care, so rationing is
an invariable consequence. The real issue is the “how” of
resource allocation. Controlling volumes through market
approaches as espoused by managed care advocates can con-
trol costs, but because health care does not proceed in a free
market, that is, it is increasingly regulated, one has to be con-
cerned about whether or not current market strategies will be
as successful as managed care proponents wish in regard to
controlled volumes, cost containment, and quality. 
What has to be guarded against is the attempt to justify lim-
iting services on the basis that decreased volume inevitably
equals decreased quality. This is a quantum leap that some
health care policy makers—and I do not mean to imply in any
way that you have participated in this—have made in the
past. It is their concern that really is at issue here because this
has been done without clinical experience to appropriately
support their positions. 
Your paper concludes with a modest proposal for creating
quality improvement through programs based on clinical data
for complex surgical procedures, and it is your hope that the
profession would take the initiative in organizing such pro-
grams. I repeat this because I think that really is a very mod-
est request and certainly has to be taken in the context of what
President Loop spoke about yesterday. 
I have a question in regard to whether or not your team has
considered a strategy for accomplishing these modest goals.
If you were to have such a strategy, would you use numerical
quotas? 
Finally, last night, while speaking with Dr Favaloro, I was
struck by the realization of how far we have come in cardiac
care, driven by cardiac surgeons over the past 30 years. This
study documents that a CABG operation in many if not most
hospitals where it is practiced can be the safest surgical ther-
apy given there. This takes into account the descriptors of our
patient populations. If we, as a specialty, have helped accom-
plish this, then we should be capable of regaining the health
policy mantle that has slipped from our hands over the past
25 years. I fully expect within the next 5 to 7 years that Dr
Reemtsma and his colleagues will return to this forum and
will give us the definitive resolution of the issue of volumes
and outcomes. 
Dr Reemtsma. We have not addressed rationing of care.
However, I would like to comment on your point about the
strategy for accomplishing these goals. I do not pretend that
the data we have submitted are definitive. I suggest that this
is an indicator of the kind of information we need to make
these decisions. Then the strategy for accomplishing this
must come through some kind of professional and public
effort. I would cite the Cardiac Advisory Committee in New
York as an example. I am skeptical about the role of govern-
ment alone, uninformed by professional information, to make
these decisions, because of the power of economic and polit-
ical forces that often dictate such policy. 
Dr Frank C. Spencer (New York, NY). As Dr Reemtsma
has already mentioned, I want to acknowledge the leadership
of Dr George Humphreys for starting the first Cardiac
Advisory Committee in New York State in the 1950s. Dr
Humphreys was chairman of surgery at Columbia University
at that time. After the enactment of the Crippled Children’s
legislation, Dr Humphreys was asked to form a committee to
assess the competence of different hospital centers for per-
forming congenital heart operation, looking at their staff and
their facilities.
He asked me to assume his responsibilities as chairman of
the committee in the late 1960s. I subsequently spent about
15 years with the committee and the subsequent State
Cardiac Advisory Committee.
I want to emphasize strongly Dr Reemtsma’s comment
about the great benefit from this form of collective study. The
unique value of the New York model is the fusion of the vol-
untary surgeons and cardiologists with the State Health
Department. The voluntary physician component, performed
without reimbursement, provides the clinical judgment to
advise the state about what action, if any, is indicated. The
cardiac committee is purely advisory to the state. This com-
bination avoids the problem of creating a monopoly in viola-
tion of the Sherman Antitrust Act. The vast majority of the
recommendations given by the committee are subsequently
followed by the State Health Department.
A major achievement in the past several years has been devel-
oping the risk-adjusted mortality rates for coronary bypass. The
benefit for everyone, as emphasized by Dr Reemtsma, is that
the collective results define what is achievable. This collegial
sharing of information is invaluable. For example, if a center
had a mortality rate of 5% with a certain type of bypass,
although comparable centers achieved a mortality rate of 2% to
3%, there is an automatic stimulus to improve.
The hazard that evolved in New York State is the inability
to keep the data confidential. This was confidential for over
20 years, but a law suit by newspapers based on the Freedom
of Information Act resulted in the state data becoming acces-
sible to the public. The Society of Thoracic Surgery on a
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national level has subsequently developed a much broader
database that should be emulated. To repeat, the goal is to
define what is achievable.
What volume of annual operations was necessary for the
mortality rate with CABG to plateau? The data presented
show a mortality plateau, but the centers are required to have
a minimal number of cases per year. I believe the minimum is
at least 200 cases per year. The question nationally is what
minimal number of cardiac operations would a center per-
form each year to achieve good results.
In the future, similar information can be sought for outer
complex operations, such as thoracic and abdominal aneurysm.
Dr Reemtsma. I agree that your experience with the
Cardiac Advisory Committee is one that gives us encourage-
ment for this blend of voluntary and regulatory control. 
In regard to your question about what level of experience is
required to reach that plateau, this is not answered definitive-
ly by our data. In the CABG operation it is probably some-
where between 200 and 400 patients per year. In aneurysms,
it is probably somewhere in the range of 20 to 40 cases per
year.
Dr Craig R. Smith (New York, NY). Although this study
did not identify a volume threshold for good results in CABG
operations in a regulated, high-volume environment like New
York, that does not mean that such a threshold does not exist
in an unregulated, high-volume environment. Los Angeles
comes to mind, with more than 50 heart teams serving a pop-
ulation less than one half that of the state of New York, as a
place where volume thresholds might be detectable. Have you
thought about addressing this question in other regions,
where coronary surgery is unregulated?
Dr Reemtsma. I think that is an important question and
one that we will address. You are correct that New York rep-
resents the extreme in regulation of cardiac surgical proce-
dures and has for years functioned under the certificate-of-
need process. California, by contrast, is an example of a
laissez-faire system. We are looking at these differences, but
we do not have the data on this yet.
Dr Charles Marrin (Lebanon, NH). The Northern New
England Cardiovascular Disease Study Group has wrestled
with the issues described in Dr Reemtsma’s paper for more
than 10 years. It is really wonderful to hear his presentation.
It is easy to pick holes in studies of this kind, and we all
have at one time or another. But the truths contained in this
article cannot be denied. I think it is important to remember
that he is not one of them, he is one of us, and he has led the
way. It is time for the rest of us to get beyond anger and
denial and to embrace outcome studies. Rather than quibbling
about methods of studies done by them, let us do the studies
ourselves and do them right. That way we will believe the
data. 
Although outcome studies are not going to go away, the
question is will they be done to us or by us? We can control
our destiny, and the choice is ours.
Dr Reemtsma. It is a pleasure to pay tribute to the
Dartmouth group for the outstanding work that you have
done, and I appreciate your comments.
Dr Jacob Kolff (Johnstown, Pa). In Pennsylvania, the hos-
pital cost-containment council has reported hospital mortali-
ty rates for surgeons and for hospitals for CABGs in 1991,
1992, and 1993. In 1993, you can divide up the hospitals into
3 groups: 13 centers doing 60 to 289 procedures with a mor-
tality rate of 3.8%; the middle group from 290 to 600 proce-
dures with a mortality rate of 2.9%; and the larger centers, 9
centers, doing 600 to 954 CABGs per year, with a low mor-
tality rate of 2.5%. 
Can we qualitatively afford to have gas stations on every
corner now that the certificate-of-need requirements in
Pennsylvania, and I think also in Ohio, have been eliminated?
Dr Reemtsma. The answer to your question is that the cer-
tificate-of-need process has survived in New York, and I think it
has served our profession and patients well. I believe that what
you are describing, the relationship between mortality rates and
outcome, was more pertinent in New York before 1990. 
We have seen data on every hospital in the state of New
York that does cardiac operations, including volume, mortali-
ty rates, and risk-adjusted mortality rate. This information was
collected under auspices of the Cardiac Advisory Committee.
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